Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Durata Therapeutics, Inc. | 3,130,824 | reported | 24 Jul 2012 | tx 3+3,130,824−16,157,707 |
| Loxo Oncology, Inc. | 65,873 | reported | 02 Apr 2015 | tx 12+3,307,003−2,893,926 |
| Ohr Pharmaceutical Inc | 37,600 | reported | 09 Sept 2022 | tx 7+347,699 |
| BioAge Labs, Inc. | 33,033 | reported | 01 Mar 2026 | tx 14+317,625−64,625 |
| Gain Therapeutics, Inc. | 15,000 | reported | 24 Jun 2025 | tx 4+51,000 |
| Coya Therapeutics, Inc. | 10,000 | reported | 02 Jan 2026 | tx 8+57,557−17,557 |
| ADMA BIOLOGICS, INC. | 7,500 | reported | 28 Feb 2020 | tx 12+2,698,450 |
| Esperion Therapeutics, Inc. | 5,047 | reported | 06 Jun 2018 | tx 26+2,218,440−3,587,543 |
| VICURON PHARMACEUTICALS INC | 2,000 | reported | 09 Sept 2003 | tx 3+137,678−100 |
| CEMPRA, INC. | 0 | reported | 08 Mar 2017 | tx 26+1,354,505−3,394,649 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Mar 2026 | EXERCISE | BioAge Labs, Inc. | 3,542 | 4.38 USD | |
| 01 Mar 2026 | EXERCISE | BioAge Labs, Inc. | 3,542 | 0.00 USD | deriv |
| 17 Feb 2026 | GRANT_AWARD | BioAge Labs, Inc. | 110,000 | 0.00 USD | deriv |
| 01 Feb 2026 | EXERCISE | BioAge Labs, Inc. | 3,541 | 4.38 USD | |
| 01 Feb 2026 | EXERCISE | BioAge Labs, Inc. | 3,541 | 0.00 USD | deriv |
| 16 Jan 2026 | EXERCISE | BioAge Labs, Inc. | 3,542 | 4.38 USD | |
| 16 Jan 2026 | EXERCISE | BioAge Labs, Inc. | 3,542 | 0.00 USD | deriv |
| 13 Jan 2026 | SALE | BioAge Labs, Inc. | 4,440 | 19.45 USD | |
| 13 Jan 2026 | SALE | BioAge Labs, Inc. | 11,663 | 20.54 USD | |
| 13 Jan 2026 | SALE | BioAge Labs, Inc. | 1,923 | 21.08 USD | |
| 13 Jan 2026 | SALE | BioAge Labs, Inc. | 8,974 | 18.43 USD | |
| 13 Jan 2026 | EXERCISE | BioAge Labs, Inc. | 27,000 | 8.39 USD | |
| 13 Jan 2026 | EXERCISE | BioAge Labs, Inc. | 27,000 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | Coya Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 18 Aug 2025 | EXERCISE | Coya Therapeutics, Inc. | 17,557 | 1.09 USD | |
| 18 Aug 2025 | EXERCISE | Coya Therapeutics, Inc. | 17,557 | 0.00 USD | deriv |
| 24 Jun 2025 | GRANT_AWARD | Gain Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 25 Feb 2025 | GRANT_AWARD | Coya Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 18 Feb 2025 | GRANT_AWARD | BioAge Labs, Inc. | 170,000 | 0.00 USD | deriv |
| 01 Jan 2025 | GRANT_AWARD | Coya Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 24 Jun 2024 | GRANT_AWARD | Gain Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 01 Jan 2024 | GRANT_AWARD | Coya Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 23 Jun 2023 | GRANT_AWARD | Gain Therapeutics, Inc. | 10,500 | 0.00 USD | deriv |
| 03 Jan 2023 | PURCHASE | Coya Therapeutics, Inc. | 10,000 | — | first after silence |
| 03 Jan 2023 | PURCHASE | Coya Therapeutics, Inc. | 5,000 | — | deriv |
3 purchases reported after at least 12 months of silence — most recent on 03 Jan 2023.